Deferasirox
- Product NDC
- 45963-454
- 11-digit product format
- 459630454
- Labeler code
- 45963
- Product ID
- 45963-454_ff13b6ff-e95c-47ed-b21b-6cac71aff318
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferasirox
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA203560
- Marketing category
- ANDA
- Marketing start
- 2019-03-22
- Marketing end
- 0000-00-00
- Substance
- DEFERASIROX
- Active strength
- 125 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 45963-454 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 45963-454 | 45963-454-30 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | 45963-454 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | ||
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 45963-454 | 45963-454-30 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203560-001 | DEFERASIROX | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | |
| A203560-002 | DEFERASIROX | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | |
| A203560-003 | DEFERASIROX | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203560-001 | AB |
| A203560-002 | AB |
| A203560-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203560-002 | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203560-003 | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A203560-001 | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION / ORAL | AB | 2016-01-26 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203560-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203560-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203560-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203560-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203560-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203560-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203560-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203560-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203560-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203560-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203560-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203560-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203560-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203560-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203560-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203560-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203560-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203560-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203560-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203560-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203560-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203560-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203560-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203560-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203560-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203560-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203560-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A203560-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A203560-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A203560-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203560-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203560-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203560-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203560-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203560-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203560-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203560-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203560-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203560-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A203560-001 | AB | 1 | 8072bd15b7f6… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A203560-001 | PC | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A203560-002 | PC | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A203560-003 | PC | 2019-04-05 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A203560-001 | PC | 2019-04-05 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A203560-002 | PC | 2019-04-05 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A203560-003 | PC | 2019-04-05 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A203560-001 | PC | 2019-04-05 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A203560-002 | PC | 2019-04-05 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A203560-003 | PC | 2019-04-05 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A203560-001 | PC | 2019-04-05 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A203560-002 | PC | 2019-04-05 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A203560-003 | PC | 2019-04-05 | ea99ee380514… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e1ec29c-8ce7-9963-3c87-cf7d9cd3b139 | Product name | 5 | 20250624 |
| 0feb0248-301d-406d-9b41-7d80ddbec8a8 | Product name | 4 | 20201216 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 45963-454-30 | Deferasirox | 30 in 1 BOTTLE | TABLET, FOR SUSPENSION | 30 | 29 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 45963-454-30 | EA - Each | 45963-454 | 3d3b6d3b-9d10-42ad-853d-6b9d954da902 | 1 | 2019-04-11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Deferasirox | DEFERASIROX | Actavis Pharma, Inc. | ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 203560 ANDA203560 45963-454 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 597768 | deferasirox 125 MG Tablet for Oral Suspension | PSN | ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95 | 29 |
| 597770 | deferasirox 250 MG Tablet for Oral Suspension | PSN | ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95 | 29 |
| 597772 | deferasirox 500 MG Tablet for Oral Suspension | PSN | ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95 | 29 |
| 597768 | deferasirox 125 MG Tablet for Oral Suspension | SCD | ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95 | 29 |
| 597770 | deferasirox 250 MG Tablet for Oral Suspension | SCD | ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95 | 29 |
| 597772 | deferasirox 500 MG Tablet for Oral Suspension | SCD | ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95 | 29 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 45963-454-30 | 45963045430 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (45963-454-30) | 2019-03-22 | 0000-00-00 | No | No | Current |